Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07606820
NA
Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea
Sponsor: The First Affiliated Hospital with Nanjing Medical University
View on ClinicalTrials.gov
Summary
A Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-10-29
Completion Date
2026-04-30
Last Updated
2026-07-21
Healthy Volunteers
No
Conditions
Interventions
DRUG
Crisugabalin(HSK16149)20mg BID
different dose
DRUG
Crisugabalin(HSK16149) 20mg qd
different dose
Locations (1)
Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Nanjing, Jiangsu, China